Emerging pollutants (EPs) are becoming more common in nature. This is a general term that primarily refers to the compounds that have the potential to enter the environment and are still largely unregulated by existing water quality regulations (Wells et al., 2010). These human-made chemicals include personal care products, pesticides, nanoparticles, microplastic and pharmaceuticals demanded by modern society (Gavrilescu et al., 2015; Egbuna et al., 2021). There are growing concerns regarding the global production of synthetic chemicals. In recent years, 400 million tons per year have been produced, and at least 50% are environmentally harmful chemicals (Gavrilescu et al., 2015). Additionally, human needs could increase EPs' demand in the contemporary world (Bunke et al., 2019).
Pharmaceuticals, including antibiotics, antidiabetic, antiepileptics, antimalarial, analgesics and anti-inflammatories, are frequently reported in freshwater and marine environments (Gavrilescu et al., 2015; Gu and Wang, 2015). Many of these drugs are not biodegraded during the wastewater treatment and are discharged in an active form to aquatic environments (Fang et al., 2012; Liu et al., 2020). Consequently, they are regularly detected in levels ranging from ng/L to mg/L. The bioavailability of pharmaceutical drugs in aquatic ecosystems has a significant ecological effect on the aquatic biota. For instance, in primary consumers such as rotifers and cladocerans, these compounds negatively affect their biological parameters (life span, reproductive rates, generation time, and population increase) (Varano et al., 2017; González-Pérez et al., 2018). On the other hand, pharmaceuticals can alter the behaviour traits of secondary consumers (fishes) and affects their ecological interaction (Brodin et al., 2014). It is documented that pharmaceutical drugs accumulate and biomagnify in the tissues of animals through the food chain (Zenker et al., 2014). Finally, they cause a decrease in the abundance and diversity of aquatic invertebrate communities (Ali et al., 2021). Despite the evident risk, pharmaceuticals are still necessary to address the current adversities, as exemplified by the COVID-19 (Coronavirus Disease 2019) pandemic (Espejo et al., 2020).
Chloroquine is an antimalarial treatment utilized for more than seven decades, given that it is a safe drug that is easy to obtain at a relatively low cost (Attia et al., 2021). It is a drug repurposing successfully used to treat various diseases in humans comprising VIH, Q fever, influenza H5N1, malaria, hepatitis C, dengue virus, zika virus, and chikungunya virus. Furthermore, it has been tested in cancer patients with promising results (Yan et al., 2013; Plantone and Koudriavtseva, 2018). From this perspective, CQ is considered a drug with current and future potential applications. Chloroquine was one of the first drugs suggested for treating coronavirus disease 2019 (COVID-19) (Colson et al., 2020). Despite limited evidence, it was very early (March 2019) announced as a promising drug candidate against COVID-19; this led to a huge demand for and substantial use of this drug (Roustit et al., 2020). Later (June 2020), it was suspended due to their safety concerns reported by researchers (WHO, 2020).
In the COVID-19 scenario, a CQ dose of 500 to 1000 mg/day for seven days was recommended (Pastick et al., 2020). For other diseases such as malaria and chikungunya virus, CQ is administered in 10 – 25 mg/kg and 250 mg daily, respectively (Taylor and White, 2004; Delogu and de Lamballerie, 2011). Approximately 50% of those amounts are excreted unchanged in the urine and feces; hence, substantial amounts of these wastes enter the aquatic environment due to inadequate treatment of residual waters (Kuroda et al., 2021). Chloroquine has a long half-life in both the human body and the environment (Olatunde et al., 2014; Kuroda et al., 2021). Because of their potential to be a persistent pollutant in water, some mechanisms for CQ degradation have been proposed, but at present, they are not implemented worldwide (Midassi et al., 2020).
Copper (Cu) is ubiquitous in the environment and are thus frequently in marine environments. The US Environmental Protection Agency has listed it as one of the priority contaminants. Cu bioavailability in the aquatic environment may be natural or influenced by anthropogenic (mining, metallurgic industry, aquaculture, agriculture, etc.) sources (Páez-Osuna and Osuna-Martínez, 2015). Cu is an essential trace element for many physiological functions (e.g., mitochondrial respiration, normal cell growth and development and antioxidant defence). However, it can be harmful to human health and aquatic life at high concentrations (Ansari et al., 2003). There is growing concerned about the toxicity of copper to aquatic invertebrates, including marine zooplankton, since this metal's presence in the medium, even at low concentrations (10 – 50 µg/L), adversely affects the population dynamics, which translates into potential risks to the trophic structure of aquatic ecosystems (Schuler et al., 2008; Kwok et al., 2008; Bao et al., 2013; Rebolledo et al., 2021). In some cases, this risk intensifies when Cu is combined with other toxic substances (Bao et al., 2014; Jia et al., 2020).
Rotifers are fundamental in the ecological structure of aquatic ecosystems. These organisms respond quickly to environmental stresses caused by heavy metals, pesticides, pharmaceuticals, among others; hence their relevance in ecotoxicological studies (Snell and Marcial, 2017). The most used endpoints to estimate ecological risk for rotifer populations are acute (LC50) and chronic (instantaneous growth rate (r)) toxicity tests (Rico-Martínez et al., 2013; González-Pérez et al., 2018). The r is a good measure of response to toxicants since it integrates potentially complex interactions among life‐history traits, including reproductive and mortality rates (Forbes and Calow, 1999), which is unattainable through acute tests.
Many aquatic organisms live in environments polluted by a cocktail of toxic substances, including heavy metals and pharmaceuticals. Despite this general assumption, the mixture toxicity of heavy metals and drugs is examined separately in most cases (Watanabe et al., 2015; Lynch et al., 2015). Few studies have examined the toxicity of mixtures like the ones mentioned above (Almeida et al., 2018; Jia et al., 2020). Taking on account (1) the current relevance of CQ as an emerging pollutant, (2) widespread Cu contamination in marine and coastal environment and (3) that in a real scenario, environmental pollutants typically occur as mixtures rather than as individual pollutants (Cedergreen 2014), this work aimed to assess the toxicity of CQ alone and in combination with Cu to the euryhaline rotifer Proales similis. The potential of this species as a reliable model organism for marine ecotoxicological studies has been previously demonstrated by Rebolledo et al. (2018), Snell et al. (2019) and Kim et al. (2021).